• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

ACCC Publication Offers Insight for Incorporating Immunotherapies Into Practice

Article

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties.

The Association of Community Cancer Centers (ACCC) has released a new report highlighting resources developed by the ACCC Immuno-Oncology Institute to meet the needs of detailed, practical insights for selecting and delivering immunotherapy, recognizing and managing immune-related toxicities, and coordinating patient care across specialties. Targeted materials developed by the institute include a how-to guide for developing an interdisciplinary toxicity team to help manage immune-related adverse events, as well as workshops and webinars focused on effective practices for multidisciplinary teams delivering these new therapies.

See more highlights from the report.

Related Videos
Douglas Flora, MD, FACCC
Fred Locke, MD, Moffitt Cancer Center and Research Institute
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Rachel Rohaidy, MD
Andrew Kuykendall, MD, Moffitt Cancer Center
Dr Rebecca Haberman
Frederick L. Locke, MD
Screenshot of an interview with Shaun McKenzie, MD
Dr Rebecca Haberman
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.